Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer

Abstract

Endothelial expression of Dll4 is not a prognostic factor, but is significantly associated with VEGF. Assessing endothelial Dll4 expression may be critical in predicting response to anti-VEGF therapies.